Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 7 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 28, 2024 Filed Aug 29, 2024 20:15 UTC |
Wills Robert JamesDirector
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0001415889-24-022532 · form4-08292024_040801.xml · derivative · entry 1 Wills Robert James · CIK 0001634189 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Shares · 40,000 shares Expires 2034-08-28 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on September 28, 2024, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 20:17 UTC |
Saik AndrewDirector
|
GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001415889-24-019668 · form4-07172024_080740.xml · derivative · entry 1 Saik Andrew · CIK 0001616284 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Shares · 80,000 shares Expires 2034-07-15 F1 · derivative.exercise_date: This option will vest in equal monthly installments, beginning on August 15, 2024, over a period of three years, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 20:15 UTC |
Duty StuartDirector
|
GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001415889-24-019664 · form4-07172024_080751.xml · derivative · entry 1 Duty Stuart · CIK 0001970274 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Shares · 80,000 shares Expires 2034-07-15 F1 · derivative.exercise_date: This option will vest in equal monthly installments, beginning on August 15, 2024, over a period of three years, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:23 UTC |
Wills Robert JamesDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $3.86 | $0.00 |
DisclosureSEC source: 0001209191-23-035844 · doc4.xml · derivative · entry 1 Wills Robert James · CIK 0001634189 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2033-06-07 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on July 7, 2023, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:22 UTC |
TOMSICEK MICHAEL JOHNDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $3.86 | $0.00 |
DisclosureSEC source: 0001209191-23-035843 · doc4.xml · derivative · entry 1 TOMSICEK MICHAEL JOHN · CIK 0001570392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2033-06-07 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on July 7, 2023, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:22 UTC |
Pasternak Richard CDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $3.86 | $0.00 |
DisclosureSEC source: 0001209191-23-035841 · doc4.xml · derivative · entry 1 Pasternak Richard C · CIK 0001792810 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2033-06-07 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on July 7, 2023, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:21 UTC |
Liebert Debra K.Director
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $3.86 | $0.00 |
DisclosureSEC source: 0001209191-23-035838 · doc4.xml · derivative · entry 1 Liebert Debra K. · CIK 0001772891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2033-06-07 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on July 7, 2023, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:21 UTC |
Giles Lisa M.Director
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $3.86 | $0.00 |
DisclosureSEC source: 0001209191-23-035836 · doc4.xml · derivative · entry 1 Giles Lisa M. · CIK 0001568850 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2033-06-07 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on July 7, 2023, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:20 UTC |
Fischer Seth H. Z.Director
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $3.86 | $0.00 |
DisclosureSEC source: 0001209191-23-035825 · doc4.xml · derivative · entry 1 Fischer Seth H. Z. · CIK 0001573553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2033-06-07 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on July 7, 2023, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 20:30 UTC |
RTW INVESTMENTS, LP10% owner
WONG RODERICK10% owner
|
OtherCommon Shares, no par value ("Common Shares") | 1,059,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000902664-23-002379 · ownership.xml · nonDerivative · entry 1 RTW INVESTMENTS, LP · CIK 0001493215 · 10% owner WONG RODERICK · CIK 0001493280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 3,256,102 F1 · kind: The RTW Funds (as defined below) exchanged 1,059,000 Common Shares for 1,059,000 pre-funded warrants pursuant to an Exchange Agreement, dated as of March 22, 2023, by and among the Issuer and the RTW Funds. Each pre-funded warrant represents the right to acquire one Common Share for an exercise price of $0.001 per share. The pre-funded warrants are subject to a 9.99% beneficial ownership limitation and do not have an expiration date. F1 · price: The RTW Funds (as defined below) exchanged 1,059,000 Common Shares for 1,059,000 pre-funded warrants pursuant to an Exchange Agreement, dated as of March 22, 2023, by and among the Issuer and the RTW Funds. Each pre-funded warrant represents the right to acquire one Common Share for an exercise price of $0.001 per share. The pre-funded warrants are subject to a 9.99% beneficial ownership limitation and do not have an expiration date. F2 · ownership.nature: This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to Common Shares held by certain investment funds managed by the Adviser (the "RTW Funds"), and (ii) Roderick Wong, M.D., who serves as the Managing Partner and Chief Investment Officer of the Adviser. Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 23:33 UTC |
Fischer Seth H. Z.Director
|
GrantStock Option (right to buy) · Derivative | 42,000 | $0.00 Strike: $3.45 | $0.00 |
DisclosureSEC source: 0001209191-23-020844 · doc4.xml · derivative · entry 1 Fischer Seth H. Z. · CIK 0001573553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Shares · 42,000 shares Expires 2033-03-21 F1 · derivative.exercise_date: This option will vest in equal monthly installments, beginning on April 21, 2023, over a period of three years, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 16:50 UTC |
Bharucha DavidChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 185,000 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001209191-23-010700 · doc4.xml · derivative · entry 1 Bharucha David · CIK 0001910985 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Shares · 185,000 shares Expires 2033-02-16 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vest on February 16, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:49 UTC |
Oliveto JosephDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 360,000 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001209191-23-010697 · doc4.xml · derivative · entry 1 Oliveto Joseph · CIK 0001437782 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Shares · 360,000 shares Expires 2033-02-16 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vest on February 16, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:52 UTC |
Muller LorenzChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 105,000 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001209191-23-010707 · doc4.xml · derivative · entry 1 Muller Lorenz · CIK 0001771207 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Shares · 105,000 shares Expires 2033-02-16 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vest on February 16, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:51 UTC |
Nelson Jeffrey EdwardChief Operating Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 105,000 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001209191-23-010705 · doc4.xml · derivative · entry 1 Nelson Jeffrey Edward · CIK 0001943112 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Shares · 105,000 shares Expires 2033-02-16 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vest on February 16, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:51 UTC |
Hasija AmitCFO & EVP of Corp. Development
|
GrantEmployee Stock Option (right to buy) · Derivative | 130,000 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001209191-23-010703 · doc4.xml · derivative · entry 1 Hasija Amit · CIK 0001787700 · CFO & EVP of Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Shares · 130,000 shares Expires 2033-02-16 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vest on February 16, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 05, 2022 Filed Dec 5, 2022 16:48 UTC |
Bharucha DavidChief Medical Officer
|
PurchaseCommon Shares | 7,000 | $4.69 | $32,830.00 |
DisclosureSEC source: 0001209191-22-059720 · doc4.xml · nonDerivative · entry 2 Bharucha David · CIK 0001910985 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 16:48 UTC |
Bharucha DavidChief Medical Officer
|
PurchaseCommon Shares | 3,000 | $4.86 | $14,580.00 |
DisclosureSEC source: 0001209191-22-059720 · doc4.xml · nonDerivative · entry 1 Bharucha David · CIK 0001910985 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Read SEC document |
| October 21, 2022 Filed Oct 21, 2022 23:02 UTC |
Liebert Debra K.Director
|
PurchaseCommon Shares | 4,000 | $5.26 | $21,040.00 |
DisclosureSEC source: 0001209191-22-054326 · doc4.xml · nonDerivative · entry 2 Liebert Debra K. · CIK 0001772891 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Trust Disclosed balance after: 4,000 F2 · ownership.nature: These shares are held in a trust for the benefit of several including the Reporting Person's spouse. The Reporting Person's spouse is a co-executor of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 20, 2022 Filed Oct 21, 2022 23:02 UTC |
Pasternak Richard CDirector
|
PurchaseCommon Shares | 10,000 | $5.20 | $52,000.00 |
DisclosureSEC source: 0001209191-22-054327 · doc4.xml · nonDerivative · entry 1 Pasternak Richard C · CIK 0001792810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.065 to $5.24 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| October 20, 2022 Filed Oct 21, 2022 23:02 UTC |
Liebert Debra K.Director
|
PurchaseCommon Shares | 10,000 | $5.29 | $52,900.00 |
DisclosureSEC source: 0001209191-22-054326 · doc4.xml · nonDerivative · entry 1 Liebert Debra K. · CIK 0001772891 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: The Rodriguez and Liebert Revocable Trust Disclosed balance after: 10,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.24 to $5.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| October 19, 2022 Filed Oct 21, 2022 23:03 UTC |
Wills Robert JamesDirector
|
PurchaseCommon Shares | 15,000 | $4.93 | $73,950.00 |
DisclosureSEC source: 0001209191-22-054328 · doc4.xml · nonDerivative · entry 1 Wills Robert James · CIK 0001634189 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.89 to $4.9494 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| October 19, 2022 Filed Oct 21, 2022 23:01 UTC |
TOMSICEK MICHAEL JOHNDirector
|
PurchaseCommon Shares | 15,000 | $5.32 | $79,800.00 |
DisclosureSEC source: 0001209191-22-054325 · doc4.xml · nonDerivative · entry 1 TOMSICEK MICHAEL JOHN · CIK 0001570392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within a one dollar range. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 20:30 UTC |
Liebert Debra K.Director
|
OtherCommon Shares | 127 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050075 · doc4.xml · nonDerivative · entry 1 Liebert Debra K. · CIK 0001772891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127 F1 · kind: Represents a pro rata distribution without additional consideration to the Reporting Person from a limited liability company in which the Reporting Person is a member. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:15 UTC |
RTW INVESTMENTS, LP10% owner
WONG RODERICK10% owner
|
SaleCommon Shares | 1,557,346 | $8.71 | $13,564,483.66 |
DisclosureSEC source: 0000902664-22-004219 · ownership.xml · nonDerivative · entry 2 RTW INVESTMENTS, LP · CIK 0001493215 · 10% owner WONG RODERICK · CIK 0001493280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,315,102 F1 · balance_after: Ordinary course rebalancing transactions in which certain RTW Funds (as defined below) rebalance holdings of the Issuer among the RTW Funds. After the transactions reported herein, the amount of Common Shares of the Issuer beneficially owned in the aggregate by the Reporting Persons did not change. F2 · ownership.nature: This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to Common Shares held by certain investment funds managed by the Adviser (the "RTW Funds"), and (ii) Roderick Wong, M.D., who serves as the Managing Partner and Chief Investment Officer of the Adviser. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:15 UTC |
RTW INVESTMENTS, LP10% owner
WONG RODERICK10% owner
|
PurchaseCommon Shares, no par value ("Common Shares") | 1,557,346 | $8.71 | $13,564,483.66 |
DisclosureSEC source: 0000902664-22-004219 · ownership.xml · nonDerivative · entry 1 RTW INVESTMENTS, LP · CIK 0001493215 · 10% owner WONG RODERICK · CIK 0001493280 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,315,102 F1 · balance_after: Ordinary course rebalancing transactions in which certain RTW Funds (as defined below) rebalance holdings of the Issuer among the RTW Funds. After the transactions reported herein, the amount of Common Shares of the Issuer beneficially owned in the aggregate by the Reporting Persons did not change. F2 · ownership.nature: This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to Common Shares held by certain investment funds managed by the Adviser (the "RTW Funds"), and (ii) Roderick Wong, M.D., who serves as the Managing Partner and Chief Investment Officer of the Adviser. Read SEC document |
| July 05, 2022 Filed Aug 11, 2022 22:05 UTC |
Pasternak Richard CDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001209191-22-045475 · doc4.xml · derivative · entry 1 Pasternak Richard C · CIK 0001792810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2032-07-05 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on August 5, 2022, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| July 05, 2022 Filed Aug 11, 2022 22:03 UTC |
TOMSICEK MICHAEL JOHNDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001209191-22-045474 · doc4.xml · derivative · entry 1 TOMSICEK MICHAEL JOHN · CIK 0001570392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2032-07-05 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on August 5, 2022, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| July 05, 2022 Filed Aug 11, 2022 22:02 UTC |
Wills Robert JamesDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001209191-22-045472 · doc4.xml · derivative · entry 1 Wills Robert James · CIK 0001634189 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2032-07-05 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on August 5, 2022, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| July 05, 2022 Filed Aug 11, 2022 22:01 UTC |
Giles Lisa M.Director
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001209191-22-045471 · doc4.xml · derivative · entry 1 Giles Lisa M. · CIK 0001568850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2032-07-05 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on August 5, 2022, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| July 05, 2022 Filed Aug 11, 2022 22:00 UTC |
Liebert Debra K.Director
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001209191-22-045468 · doc4.xml · derivative · entry 1 Liebert Debra K. · CIK 0001772891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2032-07-05 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on August 5, 2022, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 21:32 UTC |
TRUEX PAUL FDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 822 | $0.00 Strike: $2.66 | $0.00 |
DisclosureSEC source: 0001209191-22-033336 · doc4.xml · derivative · entry 9 TRUEX PAUL F · CIK 0001120362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117 Underlying: Common Shares · 822 shares Expires 2028-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on November 21, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 21:32 UTC |
TRUEX PAUL FDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 22,870 | $0.00 Strike: $1.54 | $0.00 |
DisclosureSEC source: 0001209191-22-033336 · doc4.xml · derivative · entry 8 TRUEX PAUL F · CIK 0001120362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,659 Underlying: Common Shares · 22,870 shares Expires 2028-10-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on October 15, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 21:32 UTC |
TRUEX PAUL FDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 45,072 | $0.00 Strike: $1.54 | $0.00 |
DisclosureSEC source: 0001209191-22-033336 · doc4.xml · derivative · entry 7 TRUEX PAUL F · CIK 0001120362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 45,072 shares Expires 2027-07-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested and exercisable. Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 21:32 UTC |
TRUEX PAUL FDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 8,016 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001209191-22-033336 · doc4.xml · derivative · entry 6 TRUEX PAUL F · CIK 0001120362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 8,016 shares Expires 2025-08-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested and exercisable. Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 21:32 UTC |
TRUEX PAUL FDirector
|
PurchaseCommon Shares | 5,000 | $5.60 | $28,000.00 |
DisclosureSEC source: 0001209191-22-033336 · doc4.xml · nonDerivative · entry 5 TRUEX PAUL F · CIK 0001120362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,780 Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 21:32 UTC |
TRUEX PAUL FDirector
|
Exercise / conversionCommon Shares | 822 | $2.66 | $2,186.52 |
DisclosureSEC source: 0001209191-22-033336 · doc4.xml · nonDerivative · entry 4 TRUEX PAUL F · CIK 0001120362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 21:32 UTC |
TRUEX PAUL FDirector
|
Exercise / conversionCommon Shares | 22,870 | $1.54 | $35,219.80 |
DisclosureSEC source: 0001209191-22-033336 · doc4.xml · nonDerivative · entry 3 TRUEX PAUL F · CIK 0001120362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 21:32 UTC |
TRUEX PAUL FDirector
|
Exercise / conversionCommon Shares | 45,072 | $1.54 | $69,410.88 |
DisclosureSEC source: 0001209191-22-033336 · doc4.xml · nonDerivative · entry 2 TRUEX PAUL F · CIK 0001120362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 21:32 UTC |
TRUEX PAUL FDirector
|
Exercise / conversionCommon Shares | 8,016 | $1.12 | $8,977.92 |
DisclosureSEC source: 0001209191-22-033336 · doc4.xml · nonDerivative · entry 1 TRUEX PAUL F · CIK 0001120362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2022 Filed Mar 24, 2022 01:47 UTC |
Oliveto JosephDirector · President and CEO
|
GrantEmployee Stock Option Grant (right to buy) · Derivative | 500,000 | $0.00 Strike: $5.46 | $0.00 |
DisclosureSEC source: 0001209191-22-020840 · doc4.xml · derivative · entry 1 Oliveto Joseph · CIK 0001437782 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Shares · 500,000 shares Expires 2032-03-21 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vest on March 23, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 21, 2022 Filed Mar 24, 2022 01:47 UTC |
Hasija AmitCFO & EVP of Corp. Development
|
GrantEmployee Stock Option Grant (right to buy) · Derivative | 175,000 | $0.00 Strike: $5.46 | $0.00 |
DisclosureSEC source: 0001209191-22-020839 · doc4.xml · derivative · entry 1 Hasija Amit · CIK 0001787700 · CFO & EVP of Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Shares · 175,000 shares Expires 2032-03-21 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vest on March 23, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 21, 2022 Filed Mar 24, 2022 01:46 UTC |
Muller LorenzChief Commercial Officer
|
GrantEmployee Stock Option Grant (right to buy) · Derivative | 160,000 | $0.00 Strike: $5.46 | $0.00 |
DisclosureSEC source: 0001209191-22-020838 · doc4.xml · derivative · entry 1 Muller Lorenz · CIK 0001771207 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Shares · 160,000 shares Expires 2032-03-21 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vest on March 23, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 16:48 UTC |
Bharucha DavidChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 330,000 | $0.00 Strike: $6.47 | $0.00 |
DisclosureSEC source: 0001209191-22-010812 · doc4.xml · derivative · entry 1 Bharucha David · CIK 0001910985 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,000 Underlying: Common Shares · 330,000 shares Expires 2032-02-15 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vest on February 15, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| June 14, 2021 Filed Jul 29, 2021 17:40 UTC |
TRUEX PAUL FDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.54 | $0.00 |
DisclosureSEC source: 0001209191-21-048575 · doc4.xml · derivative · entry 1 TRUEX PAUL F · CIK 0001120362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2031-06-14 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on July 14, 2021, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| June 14, 2021 Filed Jul 29, 2021 21:39 UTC |
TOMSICEK MICHAEL JOHNDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.54 | $0.00 |
DisclosureSEC source: 0001209191-21-048573 · doc4.xml · derivative · entry 1 TOMSICEK MICHAEL JOHN · CIK 0001570392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2031-06-14 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on July 14, 2021, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| June 14, 2021 Filed Jul 29, 2021 21:38 UTC |
Pasternak Richard CDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.54 | $0.00 |
DisclosureSEC source: 0001209191-21-048570 · doc4.xml · derivative · entry 1 Pasternak Richard C · CIK 0001792810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2031-06-14 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on July 14, 2021, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| June 14, 2021 Filed Jul 29, 2021 21:37 UTC |
Liebert Debra K.Director
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.54 | $0.00 |
DisclosureSEC source: 0001209191-21-048567 · doc4.xml · derivative · entry 1 Liebert Debra K. · CIK 0001772891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2031-06-14 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on July 14, 2021, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| June 14, 2021 Filed Jul 29, 2021 21:34 UTC |
Wills Robert JamesDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.54 | $0.00 |
DisclosureSEC source: 0001209191-21-048563 · doc4.xml · derivative · entry 1 Wills Robert James · CIK 0001634189 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2031-06-14 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on July 14, 2021, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
| June 14, 2021 Filed Jul 29, 2021 21:35 UTC |
Giles Lisa M.Director
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.54 | $0.00 |
DisclosureSEC source: 0001209191-21-048565 · doc4.xml · derivative · entry 1 Giles Lisa M. · CIK 0001568850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2031-06-14 F1 · derivative.exercise_date: This option will vest in twelve (12) equal monthly installments, beginning on July 14, 2021, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.